Clincosm LogoSign in Get a demo

primary mediastinal large b cell lymphoma

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

Recruiting
  • B-cell Lymphoma
  • +5 more
  • Louisville, Kentucky
    Norton Cancer Institute
Jan 24, 2023

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Nov 22, 2022

Lentiviral-based Gene-edited Immune Cell Therapy

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • Pell's lentiviral-based gene-edited immune cell therapy
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Large B-cell Lymphoma Trial in Kaohsiung, Taipei

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • CD19-targeted chimeric antigen receptor T-cell
  • Kaohsiung, Taiwan
  • +2 more
Oct 25, 2022

Mature B-Cell Tumor, Non Hodgkin Lymphoma, DLBCL Trial (SGR-1505)

Not yet recruiting
  • Mature B-Cell Neoplasm
  • +25 more
  • (no location specified)
Sep 14, 2022

Relapsed/Refractory B-cell Lymphomas, Diffuse Large B Cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in United States

Recruiting
  • Relapsed/Refractory B-cell Lymphomas
  • +11 more
  • CLBR001 and SWI019
  • Duarte, California
  • +7 more
Jul 26, 2022

B-cell Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma, Relapsed, Non-Hodgkin's Lymphoma Refractory Trial in Taipei (RPM

Terminated
  • B-cell Acute Lymphoblastic Leukemia
  • +7 more
  • RPM CD19-mbIL15-CAR-T cells
  • Taipei, Taiwan
    National Taiwan University Hospital
May 11, 2022

Refractory Non-Hodgkin Lymphoma, Burkitt Lymphoma, Mantle Cell Lymphoma Trial in San Francisco (Fludarabine, Cyclophosphamide,

Recruiting
  • Refractory Non-Hodgkin Lymphoma
  • +8 more
  • San Francisco, California
    University of California, San Francisco
May 2, 2022

Primary Mediastinal Large B Cell Lymphoma, EBV-Positive DLBCL, Nos Trial in Shanghai (Zanubrutinib, Tislelizumab)

Recruiting
  • Primary Mediastinal Large B Cell Lymphoma
  • EBV-Positive DLBCL, Nos
  • Shanghai, Shanghai, China
    Ruijin Hospital
Mar 29, 2021

Primary Mediastinal Large B Cell Lymphoma Trial in Worldwide (Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Rituximab)

Active, not recruiting
  • Primary Mediastinal Large B Cell Lymphoma
  • Etoposide, Doxorubicin, Vincristine, Cyclophosphamide, Rituximab
  • Leuven, Belgium
  • +8 more
Mar 17, 2021

Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial (Telemedicine visit)

Withdrawn
  • Large B-cell Lymphoma
  • +4 more
  • Telemedicine visit
  • (no location specified)
Oct 21, 2020

Non Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma Trial in Denver, Nashville, Houston (TC-110 T

Recruiting
  • Non Hodgkin Lymphoma
  • +5 more
  • TC-110 T Cells
  • +2 more
  • Denver, Colorado
  • +2 more
Jun 25, 2020

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Transformed Lymphoma Trial in Tianjin (BZ019)

Unknown status
  • Diffuse Large B Cell Lymphoma
  • +3 more
  • BZ019
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Mar 15, 2020

Primary Mediastinal Large B Cell Lymphoma Trial in Italy (Brentuximab Vedotin)

Completed
Has Results
  • Primary Mediastinal Large B Cell Lymphoma
  • Brentuximab Vedotin
  • Alessandria, AL, Italy
  • +8 more
Apr 10, 2017